NDC directory

Semaglutide

Semaglutide · Novo Nordisk A/S · INJECTION, SOLUTION

0420-9302DRUG FOR FURTHER PROCESSINGBulk ingredient
Product NDC
0420-9302
Generic name
Semaglutide
Labeler name
Novo Nordisk A/S
Finished
false
Listing expiration date
20271231
Marketing category
DRUG FOR FURTHER PROCESSING
Dosage form
INJECTION, SOLUTION
SPL ID
452218f4-52e8-44c0-9886-97095e9397b3
Product type
DRUG FOR FURTHER PROCESSING
Marketing start date
20260428
Product ID
0420-9302_452218f4-52e8-44c0-9886-97095e9397b3
Active ingredients
  1. Name
    SEMAGLUTIDE
    Strength
    1 mg/.5mL
Packaging
  1. Package NDC
    0420-9302-01
    Description
    1440 TRAY in 1 BOX (0420-9302-01) / 160 SYRINGE in 1 TRAY / .5 mL in 1 SYRINGE
    Marketing start date
    28-APR-26
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.